Biomarkers Industry Data Book - Cardiac Biomarkers, Cancer Biomarkers, Non-alcoholic Steatohepatitis Biomarkers, Neurological Biomarkers Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030
- Published Date: Jan, 2023
- Report ID: sector-report-00109
- Format: Electronic (PDF)
- Number of Pages: 300
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation
- 1.1.1 Estimates And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR’s Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis
- 1.6.1.1 Approach 1: Commodity Flow Approach
- 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
- 1.7 Global Market: CAGR Calculation
- 1.8 Research Assumptions
- 1.9 List of Secondary Sources
- 1.10 List of Primary Sources
- 1.11 Objectives
- 1.11.1 Objective 1
- 1.11.2 Objective 2
- 1.12 List Of Abbreviations
Chapter 2 Market Definitions
- 2.1 Definitions
Chapter 3 Executive Summary
- 3.1 Market Summary
Chapter 4 Global Biomarkers Variables, Trends, & Scope
- 4.1 Biomarkers Market Lineage Outlook
- 4.1.1 Parent Market Outlook
- 4.2 Penetration And Growth Prospect Mapping
- 4.3 Regulatory Framework
- 4.4 Market Driver Analysis
- 4.4.1 Growing Geriatric Population
- 4.4.2 Technological Advancements
- 4.4.3 Increasing Funding for Biomarkers
- 4.4.4 Growing Prevalence Of Target Diseases, And Hospital-Acquired Infections
- 4.4.5 Outbreak Of Covid-19
- 4.5 Market Restraint Analysis
- 4.5.1 Lack of Reimbursement Policies
- 4.5.2 Stringent Regulatory Policies
- 4.6 Value Chain Analysis
- 4.6.1 Value Chain Analysis/Route To Market
- 4.7 Consumer Behavior Analysis
- 4.8 Major Deals and Strategic Alliances Analysis
- 4.8.1 New product launch
- 4.8.1.1 Mergers and acquisitions
- 4.8.1.2 Expansion
- 4.8.1.3 Partnerships
- 4.8.1.4 Marketing & promotions
- 4.8.1.5 Market entry strategies
- 4.8.2 Mergers And Deals
- 4.9 Cardiac Biomarkers Market Analysis Tools
- 4.9.1 Industry Analysis - Porter’s
- 4.9.2 SWOT Analysis, By Pest
- 4.10 NASH Biomarkers Market Analysis Tools
- 4.10.1 Industry Analysis - Porter’s
- 4.10.2 SWOT Analysis, By Pest
- 4.11 Cancer Biomarkers Market Analysis Tools
- 4.11.1 Industry Analysis - Porter’s
- 4.11.2 SWOT Analysis, By Pest
- 4.12 Neurological Biomarkers Market Analysis Tools
- 4.12.1 Industry Analysis - Porter’s
- 4.12.2 SWOT Analysis, By Pest
Chapter 5 Biomarkers Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)
- 5.1 Biomarkers Market: Products Movement Analysis
- 5.2 Cardiac Biomarkers
- 5.2.1 Cardiac Biomarkers Market, 2018 - 2030 (USD (USD Million)
- 5.3 NASH Biomarkers
- 5.3.1 NASH Biomarkers Market, 2018 - 2030 (USD Million)
- 5.4 Cancer Biomarkers
- 5.4.1 Cancer Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.4 Neurological Biomarkers
- 5.4.1 Neurological Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 6 Biomarkers Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)
- 6.1 Biomarkers Market: Type Movement Analysis
- 6.2 Cardiac Biomarkers
- 6.2.1 Cardiac Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.2.2 Troponin
- 6.2.2.1 Troponin Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.2.3 CK-MB
- 6.2.3.1 CK-MB Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.2.4 Myoglobin
- 6.2.4.1 Myoglobin Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.2.5 BNP and NT-proBNP Biomarkers
- 6.2.5.1 BNP and NT-proBNP Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.2.6 Others
- 6.2.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.3 NASH Biomarkers
- 6.3.1 NASH Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.3.2 Serum Biomarkers
- 6.3.2.1 Serum Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.3.3 Hepatic Fibrosis Biomarkers
- 6.3.3.1 Hepatic Fibrosis Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.3.4 Apoptosis Biomarkers
- 6.3.4.1 Apoptosis Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.3.5 Oxidative Stress Biomarkers
- 6.3.5.1 Oxidative Stress Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.3.6 Others
- 6.3.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.4 Cancer Biomarkers
- 6.4.1 Genetic Biomarkers
- 6.4.1.1 Genetic Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.4.2 Epigenetic Biomarkers
- 6.4.2.1 Epigenetic Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.4.3 Metabolic Biomarkers
- 6.4.3.1 Metabolic Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.4.5 Proteomic Biomarkers
- 6.4.5.1 Proteomic Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.4.6 Others
- 6.4.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.5 Neurological Biomarkers
- 6.5.1 Genetic Biomarkers
- 6.5.1.1 Genetic Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.5.2 Epigenetic Biomarkers
- 6.5.2.1 Epigenetic Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.5.3 Metabolic Biomarkers
- 6.5.3.1 Metabolic Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.5.4 Proteomic Biomarkers
- 6.5.4.1 Proteomic Biomarkers Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.5.5 Others
- 6.5.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 7 Biomarkers Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)
- 7.1 Biomarkers Market: End-use Movement Analysis
- 7.2 Pharma & CRO Industry
- 7.2.1 Pharma & CRO Industry Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.3 Hospitals
- 7.3.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.4 Diagnostic Labs
- 7.4.1 Diagnostic Labs Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.5 Academic Research Institutes
- 7.5.1 Academic Research Institutes Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8 Biomarkers Market - Segment Analysis, by Region, 2018 - 2030 (USD Million)
- 8.1 Biomarkers Market: Regional Movement Analysis
- 8.2 North America
- 8.2.1 North America, SWOT Analysis
- 8.2.2 North America Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.2.3 U.S.
- 8.2.3.1 U.S. Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.2.4 Canada
- 8.2.4.1 Canada Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.3 Europe
- 8.3.1 Europe, SWOT Analysis
- 8.3.2 Europe Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.3.3 U.K.
- 8.3.3..1 U.K. Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.3.4 Germany
- 8.3.4.1 Germany Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.3.5 Spain
- 8.3.5.1 Spain Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.3.6 France
- 8.3.6.1 France Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.3.7 Italy
- 8.3.7.1 Italy Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.3.8 Russia
- 8.3.8.1 Russia Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific, SWOT Analysis
- 8.4.2 Asia Pacific Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.3 Japan
- 8.4.3.1 Japan Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.4 China
- 8.4.4.1 China Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.5 India
- 8.4.5.1 India Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.6 South Korea
- 8.4.6.1 South Korea Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.7 Singapore
- 8.4.7.1 Singapore Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.4.8 Australia
- 8.4.8.1 Australia Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5 Latin America
- 8.5.1 Latin America, SWOT Analysis
- 8.5.2 Latin America Market Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.3 Brazil
- 8.5.3.1 Brazil Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.4 Mexico
- 8.5.4.1 Mexico Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.5.5 Argentina
- 8.5.5.1 Argentina Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6 Middle East and Africa
- 8.6.1 Middle East & Africa, SWOT Analysis
- 8.6.2 Middle-East And Africa Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.3 South Africa
- 8.6.3.1 South Africa Market Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.4 United Arab Emirates
- 8.6.4.1 United Arab Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 8.6.5 Saudi Arabia
- 8.6.5.1 Saudi Arabia Biomarkers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9 Competitive Analysis
- 9.1 Recent Developments & Impact Analysis, By Key Market Participants
- 9.1.1 Ansoff Matrix
- 9.1.2 Company/Competition Categorization (Key Innovators, Market Leaders, Expansion)
- 9.1.3 Innovators
- 9.2 Vendor Landscape
- 9.2.1 List Of Key Distributors And Channel Partners
- 9.2.2 Global Biomarkers Market: Key Company Market Share Analysis, 2021
- 9.3 Public Companies
- 9.3.1 Company Market Position Analysis
- 9.3.2 Competitive Dashboard Analysis
- 9.3.3 Strategic Framework
- 9.4 Private Companies
- 9.4.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
- 9.4.2 Regional Network Map
- 9.5 Company Profiles
- 9.5.1 F. Hoffmann-La Roche Ltd.
- 9.5.1.1 Company Overview
- 9.5.1.2 Alere, Inc.
- 9.5.1.3 Financial Performance
- 9.5.1.4 Product Benchmarking
- 9.5.1.5 Strategic Initiatives
- 9.5.2 Abbott
- 9.5.2.1 Company Overview
- 9.5.2.2 Financial Performance
- 9.5.2.3 Product Benchmarking
- 9.5.2.4 Strategic Initiatives
- 9.5.3 Epigenomics AG.
- 9.5.3.1 Company Overview
- 9.5.3.2 Financial Performance
- 9.5.3.3 Product Benchmarking
- 9.5.3.4 Strategic Initiatives
- 9.5.4 General Electric
- 9.5.4.1 Company Overview
- 9.5.4.2 Financial Performance
- 9.5.4.3 Product Benchmarking
- 9.5.4.4 Strategic Initiatives
- 9.5.5 Johnson and Johnson Services, Inc.
- 9.5.5.1 Company Overview
- 9.5.5.2 Financial Performance
- 9.5.5.3 Product Benchmarking
- 9.5.5.4 Strategic Initiatives
- 9.5.6 Thermo Fisher Scientific, Inc.
- 9.5.6.1 Company Overview
- 9.5.6.2 Financial Performance
- 9.5.6.3 Product Benchmarking
- 9.5.6.4 Strategic Initiatives
- 9.5.7 Bio-Rad Laboratories, Inc.
- 9.5.7.1 Company Overview
- 9.5.7.2 Financial Performance
- 9.5.7.3 Product Benchmarking
- 9.5.7.4 Strategic Initiatives
- 9.5.8 Siemens Healthineers AG
- 9.5.8.1 Company Overview
- 9.5.8.2 Financial Performance
- 9.5.8.3 Product Benchmarking
- 9.5.8.4 Strategic Initiatives
- 9.5.9 Qiagen
- 9.5.9.1 Company Overview
- 9.5.9.2 Financial Performance
- 9.5.9.3 Product Benchmarking
- 9.5.9.4 Strategic Initiatives
- 9.5.10 Quidel Corporation
- 9.5.10.1 Company Overview
- 9.5.10.2 Financial Performance
- 9.5.10.3 Product Benchmarking
- 9.5.10.4 Strategic Initiatives
- 9.5.11 Danaher
- 9.5.11.1 Company Overview
- 9.5.11.2 Financial Performance
- 9.5.11.3 Product Benchmarking
- 9.5.11.4 Strategic Initiatives
- 9.5.12 bioMerieux SA
- 9.5.12.1 Company Overview
- 9.5.12.2 Financial Performance
- 9.5.12.3 Product Benchmarking
- 9.5.12.4 Strategic Initiatives
- 9.5.13 Merck & Co., Inc
- 9.5.13.1 Company Overview
- 9.5.13.2 Cepheid
- 9.5.13.3 Beckman Coulter
- 9.5.13.4 Leica Biosystems
- 9.5.13.5 Financial Performance
- 9.5.13.6 Product Benchmarking
- 9.5.13.7 Strategic Initiatives
- 9.5.14 Pfizer, Inc.
- 9.5.14.1 Company Overview
- 9.5.14.2 Financial Performance
- 9.5.14.3 Product Benchmarking
- 9.5.14.4 Strategic Initiatives
- 9.5.15 Laboratory Corporation of America Holdings
- 9.5.15.1 Company Overview
- 9.5.15.2 Financial Performance
- 9.5.15.3 Product Benchmarking
- 9.5.15.4 Strategic Initiatives
- 9.5.16 Affymetrix Inc
- 9.5.16.1 Company Overview
- 9.5.16.2 Financial Performance
- 9.5.16.3 Product Benchmarking
- 9.5.16.4 Strategic Initiatives
- 9.5.17 Illumina, Inc.
- 9.5.17.1 Company Overview
- 9.5.17.2 Financial Performance
- 9.5.17.3 Product Benchmarking
- 9.5.17.4 Strategic Initiatives
- 9.5.15 Agilent Technologies
- 9.5.15.1 Company Overview
- 9.5.15.2 Financial Performance
- 9.5.15.3 Product Benchmarking
- 9.5.15.4 Strategic Initiatives
- 9.5.19 Hologic, Inc.
- 9.5.19.1 Company Overview
- 9.5.19.2 Financial Performance
- 9.5.19.3 Product Benchmarking
- 9.5.19.4 Strategic Initiatives
- 9.5.20 BD
- 9.5.20.1 Company Overview
- 9.5.20.2 Financial Performance
- 9.5.20.3 Product Benchmarking
- 9.5.20.4 Strategic Initiatives
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.